Afuco™ Anti-RTN4 ADCC Therapeutic Antibody (Atinumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to RTN-4. Atinumab is an immunomodulator. It binds to reticulon 4.
Supplier Creative Biolabs
Product # AFC-TAB-242
Pricing Inquiry
Host Human
Target RTN4
Species Reactivity Human
Type ADCC enhanced antibody
Applications ELISA, FC, IP, FuncS, IF, Neut
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback